|
📣 Theoretical and Experimental Assessment of Nitrosamine Risk in Industrial Solvent Recovery -Pub
|
|
3
|
374
|
May 29, 2026
|
|
Nitrite in Amines
|
|
15
|
841
|
May 21, 2026
|
|
Something in the air−Unveiling the role of atmospheric nitrogen oxides in nitrosamine formation from amine-containing APIs: Mechanistic insights and risk assessment-Pub
|
|
2
|
395
|
April 28, 2026
|
|
Construction of a modified Arrhenius equation for predicting drug nitrosation in solid dosage form -Pub
|
|
4
|
992
|
April 21, 2026
|
|
Modeling the Impact of Excipients Selection on Nitrosamine Formation towards Risk Mitigation
|
|
18
|
5325
|
September 20, 2025
|
|
Background on Purging Factor Calculation for your Risk Assessment
|
|
7
|
1745
|
August 13, 2025
|
|
Nitrosamine Risk Mitigation Calculator (by DFE Pharma)
|
|
1
|
1438
|
August 11, 2025
|
|
Analysis of N-Nitrosodimethylamine (NDMA) in Pharmaceutical Products in the Presence of High Concentration N,N-dimethylformamide (DMF) -Pub
|
|
0
|
885
|
August 8, 2025
|
|
Synthesis of Nitroso Derivatives of Dihydropyridine Calcium Channel Blockers
|
|
5
|
777
|
July 31, 2025
|
|
Addendum to ICH M7 on Risk Assessment and Control of N-Nitrosamine Impurities
|
|
8
|
2508
|
July 3, 2025
|
|
📖 Drug Substance and Drug Product Workflows for Quality Risk Management for the Presence of Nitrosamines in Medicines-Pub
|
|
2
|
1113
|
May 27, 2025
|
|
FDA Generic Drugs Forum - Bioequivalence Approaches
|
|
2
|
1117
|
April 22, 2025
|